Co-Diagnostics’ Cosara to initiate sales activities across India and South Asia
CODX•Cosara will initiate sales activities across India and South Asia with support from a direct sales team. Co-Diagnostics expects Indian regulatory clearance and a commercial launch before year-end 2026, and the companies expect approval of Cosara’s PCR MTB test in the fourth quarter of 2026.
1. Sales and approvals
Cosara will initiate sales activities across India and South Asia, supported by a direct sales team. Co-Diagnostics said CDSCO clearance and a commercial launch in India are anticipated before year-end 2026. The company and Cosara currently expect regulatory approval of the Cosara PCR MTB test in the fourth quarter of 2026.
